Xbrane Biopharma AB (publ) (STO:XBRANE)

Xbrane Biopharma AB Revenue

Xbrane Biopharma AB had revenue of 17.34M SEK in the quarter ending March 31, 2026, a decrease of -81.41%. This brings the company's revenue in the last twelve months to 76.45M, down -66.36% year-over-year. In the year 2025, Xbrane Biopharma AB had annual revenue of 152.35M with 2.87% growth.

• Revenue (ttm): 76.45M
• Revenue Growth: -66.36%
• P/S Ratio: 3.14
• Revenue / Employee: 2.64M
• Employees: 28
• Market Cap: 240.05M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	152.35M	4.26M	2.87%
Dec 31, 2024	148.10M	-90.63M	-37.96%
Dec 31, 2023	238.73M	181.11M	314.33%
Dec 31, 2022	57.62M	46.91M	438.03%
Dec 31, 2021	10.71M	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 16, 2026

Data Sources Report a data error